Our results showed that CCL2 is also increased in Sox9‐deleted tissues, suggesting that the dysregulation of the β–catenin–CCL2 pathway due to Sox9 deletion may drive the inflammatory response and pain observed in degenerative disc disease. The gene discussed is CCL2; the disease is intervertebral disk degenerative disorder.